Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
DOD
Grant: W81XWH-20-1-0342
DOD
Grant: W81XWH-15-1-0089
DOD
Grant: 1U01CA233360-01
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics
DOD
Grant: RO1CA142746
DOD
Grant: R25CA174650
NCI NIH HHS
Grant: R01 CA142746
NCI NIH HHS
Grant: U01 CA233360
NCI NIH HHS
Grant: R01 CA239078
National Institutes of Health
Grant: 5R01CA142746-12
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines
National Institutes of Health
Grant: 2R25CA174650-06
CaNCURE: Cancer Nanomedicine Co-ops for Undergraduate Research Experiences
Fields of Study
Keywords